VaxInnate Logo

12/19/2011

VaxInnate Licenses Recombinant Flu Vaccinese  

To CJ CheilJedang Corporation, S.Korea  

      Read More

 

04/21/2011

U.S. Congressman Rush Holt Visits VaxInnate  

Lauds Government Funding  


03/30/2011

VaxInnate plots its future following HHS contract  

The approach prompted HHS to       


 
All news


VaxInnate is developing novel, proprietary vaccines for pandemic and seasonal influenza.
Using our proven technology platform, VaxInnate has the potential to produce potent vaccines for a range of infectious diseases and help meet urgent public health needs.










Vaccine

Currently marketed influenza vaccines are based on a development, production and vaccination strategy that ...


Toll-Like Receptor (TLR)

VaxInnate's TLR technology is based on the ability of "toll-like receptors" (TLRs) to recognize certain molecular patterns...


Background Biology

The immune system takes two different, yet interdependent approaches to defeating a foreign pathogen...

All technologies
VaxInnate Employees

©2011 VaxInnate, Inc.  |  Legal  |  Privacy